Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Coresh

Showing results (461-470 of 1,160) with videos related to

Pageof 116
Sort By:
Journal of the American Society of Nephrology : JASN|March 9, 2007
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) studyAnna Kottgen, Stuart D Russell, Laura R Loehr, et al.
Circulation|March 17, 2012
Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008Wayne D Rosamond, Lloyd E Chambless, Gerardo Heiss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey, Lesley A Inker, Kunihiro Matsushita, et al.
Mayo Clinic Proceedings|November 6, 2020
Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart FailureAlex M Secora, Jung-Im Shin, Yao Qiao, et al.
Circulation. Cardiovascular Imaging|June 7, 2023
Coronary Artery Calcification and One-Year Cardiovascular Disease Incidence in the 75-and-Older Population: The ARIC StudyYejin Mok, Yasuyuki Honda, Frances M Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trialsLesley A Inker, Hiddo J Lambers Heerspink, Hasi Mondal, et al.
Clinical Biochemistry|March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general populationJonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
Journal of the American Society of Nephrology : JASN|December 17, 2011
Filtration markers may have prognostic value independent of glomerular filtration rateNavdeep Tangri, Lesley A Inker, Hocine Tighiouart, et al.
Kidney International|September 4, 2017
Plasma galectin-3 levels are associated with the risk of incident chronic kidney diseaseCasey M Rebholz, Elizabeth Selvin, Menglu Liang, et al.
BMC Health Services Research|January 11, 2007
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort studyLaura C Plantinga, Nancy E Fink, Bernard G Jaar, et al.
Pageof 116

Showing results (461-470 of 1,160) with videos related to

Sort By:
Pageof 116
Journal of the American Society of Nephrology : JASN|March 9, 2007
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) studyAnna Kottgen, Stuart D Russell, Laura R Loehr, et al.
Circulation|March 17, 2012
Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008Wayne D Rosamond, Lloyd E Chambless, Gerardo Heiss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey, Lesley A Inker, Kunihiro Matsushita, et al.
Mayo Clinic Proceedings|November 6, 2020
Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart FailureAlex M Secora, Jung-Im Shin, Yao Qiao, et al.
Circulation. Cardiovascular Imaging|June 7, 2023
Coronary Artery Calcification and One-Year Cardiovascular Disease Incidence in the 75-and-Older Population: The ARIC StudyYejin Mok, Yasuyuki Honda, Frances M Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trialsLesley A Inker, Hiddo J Lambers Heerspink, Hasi Mondal, et al.
Clinical Biochemistry|March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general populationJonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
Journal of the American Society of Nephrology : JASN|December 17, 2011
Filtration markers may have prognostic value independent of glomerular filtration rateNavdeep Tangri, Lesley A Inker, Hocine Tighiouart, et al.
Kidney International|September 4, 2017
Plasma galectin-3 levels are associated with the risk of incident chronic kidney diseaseCasey M Rebholz, Elizabeth Selvin, Menglu Liang, et al.
BMC Health Services Research|January 11, 2007
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort studyLaura C Plantinga, Nancy E Fink, Bernard G Jaar, et al.
Pageof 116